Co-Diagnostics, Inc. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
Co-Diagnostics, Inc. (CODX) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $3.20 million for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-27.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2025-03-27
- Co-Diagnostics, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2023-12-31 was $139.36K.
- Co-Diagnostics, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2023-09-30 was $0.00.
- Co-Diagnostics, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2023-06-30 was $2.41M.
- Co-Diagnostics, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2023-03-31 was $657.15K, a 3.55% decline year-over-year.
- Co-Diagnostics, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $3.20M, a 370.13% increase from fiscal 2022.
- Co-Diagnostics, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $681.33K.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2023-12-31 | $139.36K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $139.36K derived: sum of 2 quarters · filed 2025-03-27 | $2.55M derived: sum of 3 quarters · filed 2025-03-27 | $3.20M 10-K · filed 2025-03-27 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $2.41M derived: sum of 2 quarters · filed 2024-11-07 | $3.06M 10-Q · filed 2024-11-07 | $3.06M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $2.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $3.06M 10-Q · filed 2024-08-08 | $3.06M derived: sum of 3 quarters · filed 2024-08-08 | $3.06M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $657.15K 10-Q · filed 2024-05-09 | $657.15K derived: sum of 2 quarters · filed 2024-05-09 | $657.15K derived: sum of 3 quarters · filed 2024-05-09 | $657.15K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $0.00 derived: sum of 2 quarters · filed 2024-03-14 | $0.00 derived: sum of 3 quarters · filed 2024-03-14 | $681.33K 10-K · filed 2024-03-14 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 derived: sum of 2 quarters · filed 2023-11-09 | $681.33K 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $681.33K 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | $681.33K 10-Q · filed 2023-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |